LISA LIVECCHI: Open Payments
NPI 1013211622 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 12 payments from 9 companies in 2025. Trend: 2023 $43 · 2024 $178 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Greer Laboratories, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
Products named: DUPIXENT, TEZSPIRE, Rhapsido, NEFFY, AIRSUPRA, Ryaltris, ORALAIR, Xembify.
Industry payments across FL — which companies pay providers there.
